Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludivine Lebourg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nephrologie & Therapeutique|May 21, 2013
[Online hemodiafiltration: is it really more expensive?]Ludivine Lebourg, Sonia Amato, Daniel Toledano, et al.
Bone|July 13, 2015
Bone impairment in oxalosis: An ultrastructural bone analysisJustine Bacchetta, Delphine Farlay, Kariman Abelin-Genevois, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2020
T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemicSophie Candon, Dominique Guerrot, Laurent Drouot, et al.
Nephrologie & Therapeutique|April 28, 2026
Diagnostic yield of hypertension evaluation in a nephrology day hospitalJean-Brieuc Jouppe, Ludivine Lebourg, Mathilde Lemoine, et al.
Viruses|March 28, 2024
Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?Anais Romero, Charlotte Laurent, Ludivine Lebourg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 19, 2022
CD86 occupancy in belatacept-treated kidney transplant patients is not associated with clinical and infectious outcomesTristan de Nattes, Ludivine Lebourg, Isabelle Etienne, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2023
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in FranceDominique Bertrand, Mélanie Brunel, Ludivine Lebourg, et al.
Microorganisms|April 27, 2024
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster DoseDominique Bertrand, Charlotte Laurent, Mathilde Lemoine, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2021
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis PatientsDominique Bertrand, Mouad Hamzaoui, Veronique Lemée, et al.
Transplantation Direct|November 22, 2021
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nephrologie & Therapeutique|May 21, 2013
[Online hemodiafiltration: is it really more expensive?]Ludivine Lebourg, Sonia Amato, Daniel Toledano, et al.
Bone|July 13, 2015
Bone impairment in oxalosis: An ultrastructural bone analysisJustine Bacchetta, Delphine Farlay, Kariman Abelin-Genevois, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2020
T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemicSophie Candon, Dominique Guerrot, Laurent Drouot, et al.
Nephrologie & Therapeutique|April 28, 2026
Diagnostic yield of hypertension evaluation in a nephrology day hospitalJean-Brieuc Jouppe, Ludivine Lebourg, Mathilde Lemoine, et al.
Viruses|March 28, 2024
Anti SARS-CoV-2 Monoclonal Antibodies in Pre-Exposure or Post-Exposure in No- or Weak Responder to Vaccine Kidney Transplant Recipients: Is One Strategy Better than Another?Anais Romero, Charlotte Laurent, Ludivine Lebourg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 19, 2022
CD86 occupancy in belatacept-treated kidney transplant patients is not associated with clinical and infectious outcomesTristan de Nattes, Ludivine Lebourg, Isabelle Etienne, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 9, 2023
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in FranceDominique Bertrand, Mélanie Brunel, Ludivine Lebourg, et al.
Microorganisms|April 27, 2024
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster DoseDominique Bertrand, Charlotte Laurent, Mathilde Lemoine, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2021
Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis PatientsDominique Bertrand, Mouad Hamzaoui, Veronique Lemée, et al.
Transplantation Direct|November 22, 2021
SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, et al.
Pageof 2